Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer.
J Urol. 1998 Nov;160(5):1668-71; discussion 1671-2.
J Urol. 1998.
PMID: 9783928
Clinical Trial.